Silo Pharma SILO Income Statement (2010-2026)

NASDAQ SILO
$2.15 -0.16 (-6.93%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Silo Pharma Quarterly Income Statement

Periods 47 quarters
Latest Jun 2026

Silo Pharma reported net income of -$0.83M for the quarter ended Jun 2026. This income statement covers 47 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2010 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
6.58M6.58M0.13M0.13M0.13M0.15M0.21M0.21M0.21M0.21M0.21M0.20M0.30M0.25M0.30M0.42M0.70M0.56M1.08M1.13M
Revenue & cost
Revenue
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M
Gross Profit
0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.00M-0.00M-0.00M
Operating items
Research & DevelopmentR&D
0.07M-0.18M0.17M0.11M0.38M0.63M0.20M0.13M0.17M0.34M0.32M0.39M0.52M1.08M0.59M0.72M0.54M-1.34M1.01M0.30M
Wages, Salaries and OtherWages
0.33M0.32M0.20M0.25M0.40M0.65M0.37M0.57M0.34M0.45M0.32M0.39M0.26M0.30M0.27M0.30M0.31M0.17M0.26M0.31M
Selling, General & AdministrativeSG&A
0.02M0.02M0.04M0.03M0.06M0.10M0.06M0.24M0.06M0.05M
Other Operating ExpensesOther Opex
0.39M1.11M0.34M0.38M0.53M0.93M0.55M0.76M0.62M0.84M0.51M0.58M0.51M0.75M0.52M0.55M0.61M2.12M-0.03M
Operating ExpensesOpex
0.48M0.96M0.54M0.51M0.97M1.67M0.82M1.13M0.79M1.18M0.90M1.02M1.03M1.83M1.11M1.27M1.15M0.78M1.59M0.93M
Operating IncomeOp. Inc
-0.46M-0.94M-0.53M-0.49M-0.95M-1.66M-0.80M-1.11M-0.77M-1.16M-0.88M-1.00M-1.01M-1.81M-1.09M-1.25M-1.15M-0.79M-1.59M-0.93M
EBIT
-0.46M-0.94M-0.53M-0.49M-0.95M-1.66M-0.80M-1.11M-0.77M-1.16M-0.88M-1.00M-1.01M-1.81M-1.09M-1.25M-1.15M-0.79M-1.59M-0.93M
Non-operating items
Non Operating Interest Expenses
483.00164.000.07M283.000.00M0.00M0.00M0.00M273.000.00M0.00M0.00M274.000.00M0.00M886.000.03M0.00M0.00M
Non Operating Investment Income
6.66M0.01M-0.16M-0.10M390.00-0.00M-0.00M923.00234.00-0.00M0.00M989.00-0.07M-0.05M-0.04M
Interest & Investment IncomeInt & Inv Inc
377.00981.000.07M0.06M0.11M0.12M0.11M0.09M0.08M0.08M0.08M0.06M0.04M0.04M0.04M0.04M0.04M
Other Non Operating IncomeOther Non Op Inc.
0.10M84.00-283.00-0.01M-0.00M-0.00M-0.00M0.09M
Non Operating IncomeNon Op. Inc.
6.96M-0.11M-0.08M-0.16M-0.03M-0.01M-0.10M0.10M0.11M0.11M0.08M0.07M0.08M0.08M0.06M0.04M0.04M-0.10M-0.05M0.10M
Net income details
EBT
6.49M-1.06M-0.60M-0.66M-0.98M-1.66M-0.91M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M-1.65M-0.83M
Tax ProvisionsTaxes
0.02M0.80M0.60M0.91M
Profit After TaxPAT
6.47M-1.06M-0.60M-0.66M-0.98M-1.66M-0.91M-1.01M-0.66M-1.13M-0.80M-0.93M-0.93M-1.73M-1.03M-1.21M-1.11M-0.88M-1.65M-0.83M
Equity Income
-0.06M-0.04M-0.07M-0.00M
Income from Non-Controlling InterestsInc. Minority
0.98M-2.11M0.91M1.01M
Income from Continuing OperationsIncome (Continuing)
6.47M-1.86M-1.21M-0.66M-0.98M-1.66M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M-1.65M-0.83M
Income from Discontinued OperationsIncome (Discontinued)
-0.09M2.73M-0.00M
Consolidated Net IncomeConsol Net Inc.
6.38M0.87M-1.21M-0.66M-0.98M-1.66M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M-1.65M-0.83M
Income towards Parent CompanyParent Net Inc
6.38M0.87M-1.21M-0.66M-0.98M-1.66M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M-1.65M-0.83M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
6.38M0.87M-1.21M-0.66M-0.98M-1.66M-1.81M-1.01M-0.66M-1.05M-0.80M-0.93M-0.93M-1.73M-1.03M-1.20M-1.11M-0.88M-1.65M-0.83M
Additional items
EPS (Basic)
0.970.14-9.18-4.97-7.37-10.92-8.61-4.82-3.19-5.12-4.19-4.58-3.24-7.05-3.45-2.88-1.79-1.58-1.80-0.76
EPS (Diluted)
48.026.79-9.18-4.97-7.37-10.92-8.61-4.82-3.19-5.12-4.19-4.58-3.24-7.05-3.45-2.88-1.79-1.58-1.80-0.76
Shares Outstanding
6.58M6.32M0.13M0.13M0.13M0.15M0.21M0.21M0.21M0.21M0.19M0.20M0.29M0.25M0.30M0.42M0.62M0.56M0.91M1.10M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.13M0.13M0.13M0.13M0.13M0.15M0.21M0.21M0.21M0.21M0.19M0.20M0.29M0.25M0.30M0.42M0.62M0.56M0.91M1.10M
EBITDA
-0.46M-0.94M-0.53M-0.49M-0.95M-1.66M-0.80M-1.11M-0.77M-1.16M-0.88M-1.00M-1.01M-1.81M-1.09M-1.25M-1.15M-0.79M-1.59M-0.93M
Interest ExpensesInt Expense
483.00164.000.07M283.000.00M0.00M0.00M0.00M273.000.00M0.00M0.00M274.000.00M0.00M886.000.03M0.00M0.00M
Tax Rate
0.29-75.74-100.00-100.00